Drugs / SYNB1934v1
last change Mar 2024 re-read 3 minutes ago

SYNB1934v1

Developed for
phenylketonuria
Investigated by
Synlogic

Trials 1

202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT05764239 Jul 2023 → Mar 2024 phenylketonuria Synlogic Terminated No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as SYNB1934v1 ClinicalTrials.gov intervention name — accepted as the source's own label NCT05764239 ↗
Route Oral “received SYNB1934v1 orally immediately after meals” NCT05764239 ↗